0001209191-23-044535.txt : 20230803
0001209191-23-044535.hdr.sgml : 20230803
20230803180335
ACCESSION NUMBER: 0001209191-23-044535
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230801
FILED AS OF DATE: 20230803
DATE AS OF CHANGE: 20230803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thomas Dolca
CENTRAL INDEX KEY: 0001768239
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38582
FILM NUMBER: 231141514
MAIL ADDRESS:
STREET 1: C/O PRINCIPIA BIOPHARMA INC.
STREET 2: 220 E. GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allakos Inc.
CENTRAL INDEX KEY: 0001564824
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454798831
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: SUITE 500
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-597-5002
MAIL ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: SUITE 500
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-01
0
0001564824
Allakos Inc.
ALLK
0001768239
Thomas Dolca
C/O ALLAKOS INC.
825 INDUSTRIAL ROAD, SUITE 500
SAN CARLOS
CA
94070
1
0
0
0
0
Stock Option (Right to buy)
5.55
2023-08-01
4
A
0
154786
0.00
A
2033-08-01
Common Stock
154786
154786
D
The option vests as to one thirty-sixth (1/36) of the shares monthly over a three year period, subject to the Reporting Person continuing as a service provider through each such date.
/s/ H. Baird Radford, III, by power of attorney
2023-08-03